Video
Author(s):
Michael Manns, MD, the Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany, explains risk factors for hepatitis C-related hepatocellular carcinoma.
Michael Manns, MD, the Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany, explains risk factors for hepatitis C-related hepatocellular carcinoma.
Patients who have had hepatitis C or cirrhosis have a greater risk of developing HCC, said Manns. However, it is difficult to confirm if clearing the virus decreases risk of HCC because almost all patients diagnosed with hepatitis C or cirrhosis are treated for the viruses, leaving no control group to compare risk factors with.
New strategies for surveillance of HCC risk are needed, says Manns. These could include understanding the connections between age and having high-alpha one fetoprotein and HCC.
Dr Caimi on Early Data for LMY-920 in R/R B-Cell NHL
Navigating a “Sea Change” in Frontline Urothelial Carcinoma Treatment
Dr Scalici on Data for IMNN-001 Plus SOC Chemotherapy in Advanced Ovarian Cancer
Dr Lin on the Safety of NKTR-255 in Enhancing Immune Recovery Post-Chemoradiation in Locally Advanced NSCLC
2 Commerce Drive
Cranbury, NJ 08512